DHADHA AJAY KUMAR received a stock award from RAPHAEL PHARMACEUTICAL INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/6/2025ACC: 0001213900-25-021172
Director
Since Jan 2025
+600K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
600K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+350K
Price / share
—
Trade value
—
% of position
20995.8%
3/5/2025
1.67K→351.67K
Total
Net shares
+350K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2025 | A · Award | +350K | — | — | 20995.8% | 1.67K | 351.67K |
| Total | +350K | $0.00 | ||||||
Derivative Transactions1
Warrant to purchase Common Stock
Direct
Converts to
Common Stock
250K shares
Shares
+250K
Strike price
1.00
Held after
250K
Exercisable
—
3/5/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant to purchase Common Stock Direct | Common Stock250K shares | 3/5/2025 | A · Award | +250K | 1.00 | — | 250K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned403.15K
Total
403.15K indirect403.15K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 403.15K | Indirect |
| Total | 403.15K | 403.15K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported